scholarly journals COVID-19 Pandemic Between Severity Facts and Prophylaxis

2021 ◽  
Vol 16 (11) ◽  
pp. 1934578X2110412
Author(s):  
Hui Liu ◽  
Wenxia Zhu ◽  
Yilin Wu ◽  
Caini Jiang ◽  
Lili Huo ◽  
...  
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Infectious Virus ◽  
Middle East Respiratory Syndrome ◽  
The Novel ◽  
Healthy Nutrition ◽  
The World ◽  
Seasonal Flu ◽  
Novel Coronavirus ◽  
Nutrition Habits

Before COVID-19, many viruses have infected humans, so what caused COVID-19 to be considered as a pandemic? COVID-19 belongs to the coronavirus family that includes severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS). This family has caused a large number of deaths all over the world. How risky is the novel coronavirus? People and their careers were disrupted, and many businesses all over the world are now closed. From here, it seems to us that this virus is something that can make people feel afraid. In this article, we will try to understand the severity of this virus, and then disclose the available ways to confront it and ways that might improve the ability to face it, either now or in the future. Upon comparing COVID-19 with seasonal flu, we have found that COVID-19 is about 10 times more deadly, although it is not the most infectious virus. In this review, we will discuss how healthy nutrition and lifestyle may help to prevent and treat diseases, and especially COVID-19. We will focus on how to follow healthy nutrition habits and lifestyles to stop the dangers of COVID-19.

scholarly journals Does the novel coronavirus 2019 like heart more than the other family members of coronaviruses?

2020 ◽  
Vol 12 (2) ◽  
pp. 156-157
Author(s):  
Mohammad Mostafa Ansari Ramandi ◽  
Mohammadreza Baay ◽  
Nasim Naderi
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Family Members ◽  
Middle East Respiratory Syndrome ◽  
The Other ◽  
The Novel ◽  
The World ◽  
Future Challenges ◽  
Novel Coronavirus ◽  
Coronavirus Infections

The disaster due to the novel coronavirus disease 2019 (COVID-19) around the world has made investigators enthusiastic about working on different aspects of COVID-19. However, although the pandemic of COVID-19 has not yet ended, it seems that COVID-19 compared to the other coronavirus infections (the Middle East Respiratory Syndrome [MERS] and Severe Acute Respiratory Syndrome [SARS]) is more likely to target the heart. Comparing the previous presentations of the coronavirus family and the recent cardiovascular manifestations of COVID-19 can also help in predicting possible future challenges and taking measures to tackle these issues.

COVID -19 infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment

2021 ◽  
Vol 27 ◽  
Author(s):  
Avneet Kaur ◽  
Vijay Bhalla ◽  
Mohammed Salahuddin ◽  
Syed Obaidur Rahman ◽  
Faheem Hyder Pottoo
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Clinical Features ◽  
Pharmacological Treatment ◽  
Middle East Respiratory Syndrome ◽  
Present Review ◽  
The Novel ◽  
The World ◽  
Novel Coronavirus ◽  
Potential Therapeutics

Abstract:: Coronavirus was first discovered during the year 1930 and since then vrious coronaviruses like HKU1, MERS-CoV , NL63 and SARS-CoV-2 had been found to infect humans. The COVID-19 pandemic caused by SARS-CoV-2 is spreading at an alarming rate thereby created health emergency around the world. SARS-CoV2 is reportedly to be originated from wet animal market of Wuhan, China. Since then the world is searching for effective way to manage and treat the COVID-19 infection. The infections has already multiplied with several folds compared to the number of person infected by Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome. In order to fill the gap of knowledge about this virus, several evidences are required to control it so more lives could be saved. The present review is based on the publicly available literature in order to explore the knowledge regarding epidemiology, virology, diagnosis, clinical features, pharmacological and therapeutic ways to treat the novel coronavirus. This can be helpful in offering novel insights and potential therapeutics in fighting this disease.

scholarly journals Coronaviruses – a new old menace

2021 ◽  
Author(s):  
Anna Golke ◽  
Karolina Piekarska ◽  
Tomasz Dzieciątkowski
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Healthcare Systems ◽  
Middle East Respiratory Syndrome ◽  
Control Measures ◽  
The Novel ◽  
Global Impact ◽  
Infection Control Measures ◽  
The World ◽  
Novel Coronavirus

current pandemic caused by novel coronavirus SARS-CoV-2 pandemic has been described as a global health emergency. The outbreak of this virus has raised a number of questions: what exactly is SARS-CoV-2? How transmissible the novel coronavirus is? How severely affected are patients infected with SARS-CoV-2? What are the risk factors for COVID-19? What are the differences between this novel coronavirus and other coronaviruses? To answer these questions, a comparative study of three pathogenic coronaviruses that primarily invade the human respiratory system and may cause death, namely, severe acute respiratory syndrome (SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Middle East respiratory syndrome coronavirus (MERS-CoV). This review describes the source of origin, transmission, and pathogenicity of these viruses. Prevention of SARS-CoV-2 spreading entails home isolation of suspected cases and those with mild illnesses and strict infection control measures at hospitals that include contact and droplet precautions. The novel coronavirus spreads faster than its two predecessors – the SARS-CoV-1 and MERS-CoV – but has lower fatality rate. The global impact of this new pandemic is still uncertain, but it is a challenge to healthcare systems around the world.

scholarly journals Extension and Advisory Services during Lockdown due to COVID-19: Efforts by KVK in Barmer District of Rajasthan

2020 ◽  
Vol 35 (1-2) ◽  
Author(s):  
Pradeep Pagaria ◽  
L. R. Choudhary ◽  
Haridayal Choudhary ◽  
Ganga Ram ◽  
Turfan Khan
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Common Cold ◽  
Large Family ◽  
Middle East Respiratory Syndrome ◽  
The Novel ◽  
Advisory Services ◽  
The Common ◽  
Novel Coronavirus

Coronavirus outbreak was first reported in Wuhan, China on 31 December, 2019. Coronavirus (CoV) is a large family of viruses that causes illness. It ranges from the common cold to more severe diseases like Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). The novel coronavirus is a new strain of virus that has not been identified in human so far.

scholarly journals Nations’ Responses and Control Measures in Confrontation with the Novel Coronavirus Disease (COVID-19) Outbreak: A Rapid Review

2020 ◽  
Author(s):  
Parinaz Tabari ◽  
Mitra Amini ◽  
Mohsen Moghadami ◽  
Mahsa Moosavi
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Management Strategies ◽  
Control Measures ◽  
Rapid Review ◽  
The Novel ◽  
Rapid Rate ◽  
The World ◽  
Novel Coronavirus ◽  
And Control

The outbreak of Coronavirus disease 2019 (COVID-19) has posed a significant concern in many countries due to the rapid rate of transmission between humans. Taking advantage of the experience of the last epidemics in 2002 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and 2012 Middle East Respiratory Syndrome Coronavirus (MERS-CoV), some regions of the world were well- prepared for the new outbreak. However, other countries needed to be adapted to the situation promptly. Many management strategies were established, and some restrictions were introduced in some regions. In this review, we aimed to determine countries’ public responses to the epidemic of COVID-19 and how they developed administrative approaches towards the outbreak.

scholarly journals The necessity for carnivore experimentation in predicting the next zoonotic disease epidemic

2022 ◽  
pp. 1-3
Author(s):  
Freeha Anjum ◽  
Hillary Hale
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Infectious Diseases ◽  
Novel Species ◽  
Middle East Respiratory Syndrome ◽  
The Novel ◽  
The Public ◽  
Bodily Fluids ◽  
Novel Coronavirus ◽  
Human Infections

Zoonoses are human infections or diseases caused by disease spillover from vertebrate animals to people [1]. Spillover is the movement of pathogens from their normal host to a novel species [2]; this can occur through bodily fluids, bites, food, water, or contact with surfaces where infected animals have travelled [3]. Although some zoonoses remain established within populations and primarily affect only one person per spillover (classified as enzootic zoonoses—e.g., rabies), others can be transmitted between people and result in localized, or even global outbreaks [4]. Zoonoses account for over 60% of infectious diseases in humans [4] and can be caused by viruses, parasites, bacteria, or fungi. Of these, viral zoonoses prove to be of greatest detriment to the public on a widespread scale, as they are responsible for numerous epidemics and pandemics, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and the novel coronavirus (COVID-19) [5-7]. Research has also been conducted on different taxonomic orders of species, such as Carnivora — placental animals which obtain nutrients from flesh — and their viral spillover risk [11].

scholarly journals Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus

2020 ◽  
Vol 41 (04) ◽  
pp. 568-578 ◽  
Author(s):  
Jaffar A. Al-Tawfiq ◽  
Ziad A. Memish
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Emerging Infectious Diseases ◽  
Case Fatality ◽  
Severe Pneumonia ◽  
Middle East Respiratory Syndrome ◽  
Zoonotic Pathogen ◽  
Clinical Presentations ◽  
The World ◽  
Novel Coronavirus

AbstractEmerging infectious diseases continue to be of a significant importance worldwide with the potential to cause major outbreaks and global pandemics. In 2002, the world had witnessed the appearance of the severe acute respiratory syndrome coronavirus in China which disappeared abruptly within 6 months. About a decade later, a new and emerging novel coronavirus named the Middle East respiratory syndrome coronavirus (MERS-CoV) was described in a patient from Saudi Arabia. These two coronaviruses shared multiple similarities in the epidemiology, clinical presentations, and posed challenges in its prevention and management. Seven years since its discovery, MERS-CoV continues to be a lethal zoonotic pathogen capable of causing severe pneumonia with high case fatality rates and the ability to cause large health care-associated outbreaks.

Recent Patents and Advances on Nanotechnologies against Coronavirus

2020 ◽  
Vol 14 ◽  
Author(s):  
Roozbeh Abedini-Nassab ◽  
Naeemeh Mahdaviyan
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Genome Sequencing ◽  
Middle East Respiratory Syndrome ◽  
Detection Methods ◽  
Prevention Strategies ◽  
Infected People ◽  
The Third ◽  
The World ◽  
Novel Coronavirus

: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the seven known coronaviruses infecting humans; HKU1, 229E, NL63, OC43, acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-2, the last three of which can cause severe symptoms in patients. COVID-19, previously known as 2019 novel coronavirus, caused by SARS-CoV-2, was first reported in Wuhan, China, in late 2019, and quickly resulted in a major epidemic across the world. Although the origin of SARS-CoV-2 is not clear yet, genome sequencing results suggest that this is the third reported spillover of an animal coronavirus to humans, from 2002. The development of detection, therapeutic, and prevention strategies for COVID-19 is a fundamental task towards curing infected people and competing with the pandemic. Because of their similarities, scientists believe that treatment/detection methods similar to what were used against the illnesses caused by SARS-CoV or MERS-CoV may be effective for curing/detecting COVID-19. Here, we review the recent nanotechnology techniques used for treating and testing SARS-CoV, MERS-CoV, and SARS-CoV-2, and potential therapeutic options for curing COVID-19.

A Review of the Virology of SARS-CoV-2

2020 ◽  
Vol 7 (1) ◽  
pp. 69-77
Author(s):  
Aldonna Maria Susngi ◽  
◽  
Clara Ermine Sawian
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Causative Agent ◽  
Middle East Respiratory Syndrome ◽  
The Novel ◽  
Highly Pathogenic ◽  
Key Features

The novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), the causative agent of Coronavirus disease 2019 (COVID-19) is a β-coronavirus, which also includes the highly pathogenic severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome Coronavirus (MERS-CoV). Emerging in December 2019 from Wuhan, China, it has spread worldwide resulting in a pandemic that has not ended till date. This review highlights some of the key features of the virology of SARS-CoV-2.

Tri-primer-enhanced strand exchange amplification combined with rapid lateral flow fluorescent immunoassay to detect SARS-CoV-2

The Analyst ◽  
2021 ◽  
Author(s):  
Linlin Zhuang ◽  
Jiansen Gong ◽  
Ming Ma ◽  
Yongxin Ji ◽  
Peilong Tian ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Lateral Flow ◽  
Strand Exchange ◽  
The Novel ◽  
The World ◽  
Novel Coronavirus

The novel coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been surging rapidly around the world, which exposes humanity to unprecedented economic, social and...

Sign in / Sign up

Export Citation Format

Share Document